Skip to content

Clinical trials

Phase 1 Lymphoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1 Country / region: Japan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20112
20122
20132
20151
20162
20174
20181
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Eli Lilly and Company2
GlaxoSmithKline2
Pfizer2
AbbVie1
AstraZeneca1
Bayer1
Calithera Biosciences, Inc1
Daiichi Sankyo Co., Ltd.1
Eisai Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma19
Lymphoma, Non-Hodgkin4
Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Leukemia2
Lymphoma, Follicular2
Lymphoma, Mantle-Cell2
Lymphoma, T-Cell, Peripheral2
Multiple Myeloma2
Adenocarcinoma1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.